Basic Study
Copyright ©The Author(s) 2018.
World J Gastroenterol. Mar 7, 2018; 24(9): 971-981
Published online Mar 7, 2018. doi: 10.3748/wjg.v24.i9.971
Table 4 Fluoroquinolone resistance rates and the distribution of resistance-mediating mutations
GenotypeNumber of gastric biopsy specimens n (%)
P value1
All patients 165 (100)Treatment Naïve 105 (63.6)Previously treated 60 (36.4)
FluoroquinoloneS (WT)132 (80.0)89 (84.8)43 (71.7)
FluoroquinoloneR33 (20.0)16 (15.2)17 (28.3)NS
Point mutations
gyr91 D91Y18 (54.5)10 (62.5)8 (47.1)NS
gyr91 D91N6 (18.2)2 (12.5)4 (23.5)NS
gyr91 D91G2 (6.1)0 (0.0)2 (11.8)NS
gyr91 D91N + gyr91 D91G2 (6.1)1 (6.3)1 (5.9)NS
gyr91 D91N +gyr91 D91Y2 (6.1)1 (6.3)1 (5.9)NS
gyr87 N87K1 (3.0)1 (6.3)0 (0.0)NS
gyr87 N87K + gyr91 D91N + gyr91 D91G1 (3.0)0 (0.0)1 (5.9)NS
gyr87 N87K + gyr91 D91N + gyr91 D91G + gyr91 D91Y1 (3.0)1 (6.3)0 (0.0)NS